Guardamagna, M.; Berciano-Guerrero, M.-A.; Villaescusa-González, B.; Perez-Ruiz, E.; Oliver, J.; Lavado-Valenzuela, R.; Rueda-Dominguez, A.; Barragán, I.; Queipo-Ortuño, M.I.
Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition. Int. J. Mol. Sci. 2022, 23, 11990.
https://doi.org/10.3390/ijms231911990
AMA Style
Guardamagna M, Berciano-Guerrero M-A, Villaescusa-González B, Perez-Ruiz E, Oliver J, Lavado-Valenzuela R, Rueda-Dominguez A, Barragán I, Queipo-Ortuño MI.
Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition. International Journal of Molecular Sciences. 2022; 23(19):11990.
https://doi.org/10.3390/ijms231911990
Chicago/Turabian Style
Guardamagna, Mora, Miguel-Angel Berciano-Guerrero, Beatriz Villaescusa-González, Elisabeth Perez-Ruiz, Javier Oliver, RocÃo Lavado-Valenzuela, Antonio Rueda-Dominguez, Isabel Barragán, and MarÃa Isabel Queipo-Ortuño.
2022. "Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition" International Journal of Molecular Sciences 23, no. 19: 11990.
https://doi.org/10.3390/ijms231911990
APA Style
Guardamagna, M., Berciano-Guerrero, M.-A., Villaescusa-González, B., Perez-Ruiz, E., Oliver, J., Lavado-Valenzuela, R., Rueda-Dominguez, A., Barragán, I., & Queipo-Ortuño, M. I.
(2022). Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition. International Journal of Molecular Sciences, 23(19), 11990.
https://doi.org/10.3390/ijms231911990
